- •Foreword
- •Preface
- •List of Contributors
- •Acknowledgments
- •Dedication
- •In Memorium
- •DEFINITIONS
- •EPIDEMIOLOGIC AND SOCIOECONOMIC ASPECTS OF THE GLAUCOMAS
- •RISK FACTORS
- •CLASSIFICATION OF THE GLAUCOMAS
- •REFERENCES
- •Aqueous humor formation
- •FUNCTION OF AQUEOUS HUMOR
- •ANATOMY OF THE CILIARY BODY
- •STRUCTURE
- •ULTRASTRUCTURE OF THE CILIARY PROCESSES
- •VASCULAR SUPPLY
- •MECHANISM OF AQUEOUS FORMATION
- •ULTRAFILTRATION
- •ACTIVE TRANSPORT
- •DIFFUSION
- •CHEMICAL COMPOSITION OF THE AQUEOUS HUMOR
- •THE BLOOD–AQUEOUS BARRIER
- •PRESSURE-DEPENDENT TECHNIQUES
- •Tonography
- •Suction cup
- •Perfusion
- •TRACER METHODS
- •Photogrammetry
- •Radiolabeled isotopes
- •Fluorescein
- •Fluoresceinated dextrans
- •Paraminohippurate
- •Iodide
- •FACTORS AFFECTING AQUEOUS HUMOR FORMATION
- •DIURNAL VARIATION
- •INTRAOCULAR PRESSURE/PSEUDOFACILITY
- •BLOOD FLOW TO THE CILIARY BODY
- •NEURAL CONTROL
- •HORMONAL EFFECTS
- •INTRACELLULAR REGULATORS
- •CLINICAL ASPECTS OF AQUEOUS HUMOR FORMATION
- •CLINICAL CONDITIONS
- •PHARMACOLOGIC AGENTS
- •SURGERY
- •REFERENCES
- •PHYSIOLOGY ISSUES UNIQUE TO THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •FUNCTIONS OF THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •ANATOMY OF THE CONVENTIONAL OUTFLOW SYSTEM
- •SCHWALBE’S LINE
- •SCLERAL SPUR
- •TRABECULAR MESHWORK TISSUES
- •Uveal meshwork
- •Corneoscleral meshwork
- •Uveal and corneoscleral meshwork ultrastructure
- •Juxtacanalicular space and cells
- •SCHLEMM’S CANAL
- •Overview
- •Schlemm’s canal inner wall endothelium
- •Glycocalyx
- •Distending cells that form invaginations or pseudovacuoles, ‘giant vacuoles’
- •Schlemm’s canal endothelium pores
- •Sonderman’s canals invaginate into the trabecular meshwork
- •Septa
- •Schlemm’s canal valves spanning across Schlemm’s canal
- •Herniations or protrusions of Schlemm’s canal inner wall
- •Collector channels, aqueous veins and episcleral veins
- •RESISTANCE SITES IN THE AQUEOUS OUTFLOW SYSTEM
- •JUXTACANALICULAR SPACE RESISTANCE
- •SCHLEMM’S CANAL ENDOTHELIUM RESISTANCE
- •PRINCIPLES OF BIOMECHANICS AS A METHODOLOGY TO IDENTIFY TISSUE RESISTANCE
- •TISSUE LOADING STUDIES
- •BOUNDARY CONDITIONS
- •EVIDENCE FROM EXPERIMENTAL MICROSURGERY
- •AQUEOUS OUTFLOW PHYSIOLOGY: PASSIVE AND DYNAMIC FLOW MODELS
- •THE AQUEOUS OUTFLOW SYSTEM AS A PASSIVE FILTER
- •THE AQUEOUS OUTFLOW SYSTEM AS A DYNAMIC MECHANICAL PUMP
- •EXTRINSIC PRESSURE REGULATION MECHANISMS
- •UVEOSCLERAL FLOW
- •METHODS FOR MEASURING FACILITY OF OUTFLOW
- •FACILITY OF OUTFLOW CALCULATIONS
- •Tonography
- •Perfusion
- •Suction cup
- •FACILITY OF OUTFLOW AND ITS CLINICAL IMPLICATIONS
- •FACTORS AFFECTING THE FACILITY OF OUTFLOW
- •HORMONES
- •CILIARY MUSCLE TONE
- •DRUGS
- •SURGICAL THERAPY
- •DIURNAL FLUCTUATION
- •GLAUCOMA
- •EPISCLERAL VENOUS PRESSURE
- •REFERENCES
- •Intraocular pressure
- •INSTRUMENTS FOR MEASURING INTRAOCULAR PRESSURE
- •APPLANATION INSTRUMENTS
- •Goldmann tonometer
- •Perkins tonometer
- •Draeger tonometer
- •MacKay-Marg and Tono-Pen™ tonometers
- •Pneumatic tonometer
- •Non-contact tonometer
- •The Ocuton™ tonometer
- •Maklakow tonometer
- •INDENTATION INSTRUMENTS
- •Schiøtz tonometer
- •Electronic Schiøtz tonometer
- •Impact–rebound tonometer
- •Transpalpebral tonometry
- •DYNAMIC CONTOUR TONOMETRY
- •CONTINUOUS MONITORING OF INTRAOCULAR PRESSURE
- •SUMMARY OF TONOMETRY
- •DISTRIBUTION OF INTRAOCULAR PRESSURE IN THE GENERAL POPULATION
- •FACTORS THAT INFLUENCE INTRAOCULAR PRESSURE
- •RACE
- •HEREDITY
- •DIURNAL VARIATION
- •SEASONAL VARIATION
- •CARDIOVASCULAR FACTORS
- •EXERCISE
- •WIND INSTRUMENT PLAYING
- •LIFESTYLE
- •POSTURAL CHANGES
- •NEURAL FACTORS
- •PSYCHIATRIC DISORDERS
- •HORMONAL FACTORS
- •REFRACTIVE ERROR
- •FOODS AND DRUGS
- •MISCELLANEOUS
- •EYE MOVEMENTS
- •EYELID CLOSURE
- •INFLAMMATION
- •SURGERY
- •REFERENCES
- •Gonioscopic anatomy
- •GROSS ANATOMY
- •ANATOMIC FEATURES OF NORMAL EYES
- •GONIOSCOPIC ANATOMY AND MICROSCOPIC INTERPRETATION
- •PUPIL AND IRIS
- •CILIARY BODY, IRIS PROCESSES, AND SYNECHIAE
- •SCLERAL SPUR
- •SCHWALBE’S LINE
- •TRABECULAR MESHWORK AND TRABECULAR PIGMENT BAND
- •GONIOSCOPIC APPEARANCE
- •REFERENCES
- •Methods of gonioscopy
- •DEFINITION
- •METHODS OF GONIOSCOPY
- •EQUIPMENT
- •Goldmann and Zeiss lenses (indirect method)
- •Koeppe lens (direct method)
- •TECHNIQUE
- •Indirect gonioscopic lenses
- •Indentation (compression) gonioscopy
- •Direct gonioscopic lens
- •REFERENCES
- •GRADING OF CHAMBER ANGLE
- •DIAGRAMMING ANGLE WIDTH, SYNECHIAE, AND PIGMENTATION
- •TRABECULAR PIGMENT BAND
- •SPAETH CLASSIFICATION
- •STEP 4: TRABECULAR MESHWORK PIGMENTATION
- •EXAMPLES
- •DIFFICULTIES AND ARTIFACTS IN GONIOSCOPY
- •CLINICAL USEFULNESS OF GONIOSCOPY
- •AID IN DIAGNOSIS OF TYPE OF GLAUCOMA
- •EVALUATION OF SYMPTOMS
- •USE OF DRUGS
- •POSTOPERATIVE EXAMINATIONS
- •CONDITIONS OTHER THAN GLAUCOMA
- •SUMMARY OF IMPORTANT GONIOSCOPIC TECHNIQUES
- •REFERENCES
- •APPENDIX
- •Visual field theory and methods
- •THE NORMAL VISUAL FIELD
- •VISUAL ACUITY VERSUS VISUAL FIELD
- •TERMINOLOGY AND DEFINITIONS
- •THEORY OF VISUAL FIELD TESTING
- •KINETIC PERIMETRY
- •STATIC PERIMETRY
- •THRESHOLD-RELATED TESTING
- •ZONE TESTING
- •SCREENING TESTS
- •OTHER STATIC TESTING TECHNIQUES
- •THE FUTURE OF VISUAL FIELD TESTING
- •COMBINED STATIC AND KINETIC PERIMETRY
- •REFERENCES
- •PATIENT VARIABLES
- •FIXATION
- •RELIABILITY
- •OCULAR VARIABLES
- •PUPIL SIZE
- •MEDIA CLARITY
- •REFRACTIVE CORRECTION
- •TESTING VARIABLES
- •TECHNICIAN
- •BACKGROUND ILLUMINATION
- •STIMULUS SIZE AND INTENSITY
- •STIMULUS EXPOSURE TIME
- •AREA TESTED
- •EQUIPMENT AND TECHNIQUES
- •GENERAL PRINCIPLES
- •TANGENT SCREEN
- •BOWL PERIMETRY
- •Preparing the patient
- •Technique of computerized bowl perimetry
- •REFERENCES
- •Visual field interpretation
- •GLAUCOMATOUS CHANGES IN THE VISUAL FIELD
- •ANATOMY OF VISUAL FIELD DEFECTS
- •TYPES OF VISUAL FIELD LOSS
- •Generalized loss
- •Localized defects (scotomata)
- •GLAUCOMATOUS VISUAL FIELD DEFECTS
- •Generalized depression
- •Irregularity of the visual field
- •Nasal step or depression
- •Temporal step or depression
- •Enlargement of the blind spot
- •Isolated paracentral scotomata
- •Arcuate defects (nerve fiber bundle defects)
- •End-stage defects
- •Central and temporal islands
- •Reversal of visual field defects
- •ANALYSIS OF VISUAL FIELD LOSS
- •CHRONIC OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •OTHER CAUSES
- •ESTERMAN DISABILITY RATING
- •ANALYSIS OF COMPUTERIZED STATIC PERIMETRY
- •RELIABILITY INDEXES
- •False-positive and false-negative responses
- •Fixation reliability
- •FLUCTUATION
- •Short-term fluctuation
- •Long-term fluctuation
- •GLOBAL INDEXES
- •Mean sensitivity
- •Mean deviation or defect
- •Standard deviation or variance
- •GRAPHIC PLOTS
- •AREA OF THE VISUAL FIELD TO BE TESTED
- •LONG-TERM ANALYSIS
- •DETERMINATION OF NORMAL VISUAL FIELD
- •DEVIATION FROM NORMAL VALUES
- •Graphic plot of points varying from normal
- •Global indexes
- •Comparison with the other eye
- •Localized variation within the visual field
- •RECOGNITION OF CHANGE
- •QUANTIFYING VISUAL FIELD CHANGE
- •THE FUTURE OF COMPUTERIZED PERIMETRY
- •REFERENCES
- •Other psychophysical tests
- •INTRODUCTION
- •COLOR VISION AND SHORT-WAVELENGTH AUTOMATED PERIMETRY
- •FREQUENCY-DOUBLING PERIMETRY
- •OTHER PSYCHOPHYSICAL TESTS
- •HIGH-PASS RESOLUTION PERIMETRY
- •MOTION DETECTION PERIMETRY
- •ELECTROPHYSIOLOGY
- •The electroretinogram (ERG)
- •The pattern electroretinogram (PERG)
- •The multifocal electroretinogram (mfERG)
- •The multifocal visual-evoked potential (mfVEP)
- •REFERENCES
- •ANATOMY OF THE OPTIC NERVE HEAD
- •WHERE ARE THE GANGLION CELLS INJURED?
- •WHAT INJURES GANGLION CELLS?
- •Ganglion Cell Susceptibility
- •Connective tissue structures within the optic nerve head
- •Vascular nutrition of the optic disc
- •REFERENCES
- •CLINICAL TECHNIQUES OF EVALUATION
- •OPTIC DISC CHANGES IN GLAUCOMA
- •INTRAPAPILLARY DISC CHANGES
- •Optic disc size
- •Optic disc shape
- •Neuroretinal rim size (NRR)
- •Neuroretinal rim shape
- •Optic cup size in relation to optic disc size
- •Optic cup configuration and depth
- •Cup:disc ratios
- •Position of central retinal vessels and branches
- •PERIPAPILLARY DISC CHANGES
- •Optic disc hemorrhages
- •Nerve fiber layer defects
- •Diameter of retinal arterioles
- •Peripapillary choroidal atrophy
- •PATTERNS OF OPTIC NERVE CHANGES AND SUBTYPES OF GLAUCOMA
- •HIGH MYOPIA DISC PATTERN
- •FOCAL NORMAL-PRESSURE PATTERN (FOCAL ISCHEMIC)
- •AGE-RELATED ATROPHIC PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (SENILE SCLEROTIC)
- •JUVENILE OPEN-ANGLE GLAUCOMA PATTERN
- •PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (GENERALIZED ENLARGEMENT)
- •REFERENCES
- •Optic nerve imaging
- •CONFOCAL SCANNING LASER OPHTHALMOSCOPY (CSLO)
- •HEIDELBERG RETINA TOMOGRAPHY (HRT)
- •Components of the HRT report
- •Evaluating scan quality
- •Strengths and limitations
- •New developments
- •Testing from the patient’s perspective
- •OPTICAL COHERENCE TOMOGRAPHY (OCT)
- •DIFFERENT SCANNING MODALITIES
- •Peripapillary scan
- •Macular scan
- •ONH scan
- •Fast scans
- •COMPONENTS OF THE OCT REPORT
- •RNFL thickness average analysis
- •Macular analysis
- •Optic nerve head analysis
- •QUALITY ASSESSMENT
- •STRENGTHS AND LIMITATIONS
- •TESTING FROM THE PATIENT’S PERSPECTIVE
- •LONGITUDINAL EVALUATIONS
- •SCANNING LASER POLARIMETRY
- •Components of the GDX report
- •Quality assessment
- •Strengths and limitations
- •Testing from the patient’s perspective
- •CONCLUSIONS
- •REFERENCES
- •Primary angle-closure glaucoma
- •HISTORICAL REVIEW AND CLASSIFICATIONS
- •CLASSIFICATIONS OF ANGLE-CLOSURE DISEASE
- •TWENTY-FIRST CENTURY CONSENSUS CLASSIFICATION
- •CLARIFICATIONS AND COMMENTARY
- •PRESENTATIONS OF PRIMARY ANGLE-CLOSURE DISEASE
- •NEW IMAGING TECHNOLOGIES
- •CLASSIFICATION BY MECHANISMS IN THE ANTERIOR SEGMENT
- •PUPILLARY BLOCK GLAUCOMA
- •Epidemiologic studies
- •Demographic risk factors
- •Gender
- •Heredity
- •Refractive error
- •Miscellaneous factors
- •Ocular risk factors and mechanisms
- •Iris bowing and lens–iris channel
- •Provocative tests
- •Clinical presentations of acute PACG with pupillary block
- •Signs and symptoms
- •Clinical examination
- •Treatment of acute PACG
- •Medical management of acute PACG
- •Slit-lamp maneuvers in management of acute PACG
- •Laser interventions for acute PACG
- •Surgical management of PACG
- •Management of the fellow eye
- •Sequelae of acute PACG
- •Correlating older and newer terminologies for angle closure
- •PLATEAU IRIS
- •Plateau iris configuration
- •Plateau iris syndrome
- •Pseudoplateau iris (cysts of the iris and ciliary body)
- •PHACOMORPHIC GLAUCOMA
- •Intumescent and swollen lens
- •REFERENCES
- •OVERVIEW OF TERMS AND MECHANISMS
- •ANTERIOR PULLING MECHANISM
- •NEOVASCULAR GLAUCOMA
- •Histopathology
- •Pathogenesis
- •Conditions and diseases commonly associated with neovascular glaucoma
- •Diabetes mellitus
- •Central retinal vein occlusion
- •Carotid occlusive disease
- •Ocular ischemic syndrome
- •Central retinal artery occlusion
- •Miscellaneous
- •Clinical presentation
- •Treatment
- •IRIDOCORNEAL ENDOTHELIAL SYNDROME
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Progressive (essential) iris atrophy
- •Chandler’s syndrome
- •Cogan-Reese syndrome
- •Treatment
- •POSTERIOR POLYMORPHOUS DYSTROPHY
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Treatment
- •EPITHELIAL DOWNGROWTH
- •Pathophysiology
- •Histopathology
- •Clinical presentation
- •Treatment
- •FIBROVASCULAR INGROWTH
- •FLAT ANTERIOR CHAMBER
- •INFLAMMATION
- •PENETRATING KERATOPLASTY
- •IRIDOSCHISIS
- •ANIRIDIA
- •POSTERIOR PUSHING (OR ROTATIONAL) MECHANISM
- •CILIARY BLOCK GLAUCOMA (AQUEOUS MISDIRECTION OR MALIGNANT GLAUCOMA)
- •INTRAOCULAR TUMORS
- •NANOPHTHALMOS
- •SUPRACHOROIDAL HEMORRHAGE
- •POSTERIOR SEGMENT INFLAMMATORY DISEASE
- •Treatment
- •CENTRAL RETINAL VEIN OCCLUSION
- •SCLERAL BUCKLING PROCEDURE
- •PANRETINAL PHOTOCOAGULATION
- •RETINOPATHY OF PREMATURITY
- •PUPILLARY BLOCK MECHANISMS
- •Secondary pupillary block glaucoma: iris–lens adhesions
- •Dislocated and subluxed lens
- •Ectopia lentis
- •Microspherophakia
- •REFERENCES
- •Primary open angle glaucoma
- •EPIDEMIOLOGY
- •PREVALENCE
- •PATHOPHYSIOLOGY
- •DIMINISHED AQUEOUS HUMOR OUTFLOW FACILITY
- •Altered corticosteroid metabolism
- •Dysfunctional adrenergic control
- •Abnormal immunologic processes
- •Oxidative damage
- •Other toxic influences
- •OPTIC NERVE CUPPING AND ATROPHY
- •CLINICAL FEATURES
- •FINDINGS
- •DIFFERENTIAL DIAGNOSIS
- •TREATMENT
- •INDICATIONS
- •GOALS
- •Target pressure
- •TYPES OF TREATMENT
- •PROGNOSIS
- •THE GLAUCOMA SUSPECT AND OCULAR HYPERTENSION
- •EPIDEMIOLOGY OF OCULAR HYPERTENSION
- •RISK FACTORS FOR DEVELOPMENT OF OPEN-ANGLE GLAUCOMA
- •TREATMENT
- •NORMAL-TENSION GLAUCOMA
- •PATHOGENESIS
- •CLINICAL FEATURES
- •DIFFERENTIAL DIAGNOSIS
- •WORK-UP
- •TREATMENT
- •REFERENCES
- •Secondary open angle glaucoma
- •PIGMENTARY GLAUCOMA
- •EXFOLIATION SYNDROME (PSEUDOEXFOLIATION SYNDROME)
- •CORTICOSTEROID GLAUCOMA
- •LENS-INDUCED GLAUCOMA
- •PHACOLYTIC GLAUCOMA
- •LENS-PARTICLE GLAUCOMA
- •PHACOANAPHYLAXIS
- •GLAUCOMA AFTER CATARACT SURGERY
- •GLAUCOMA FROM VISCOELASTIC SUBSTANCES
- •GLAUCOMA WITH PIGMENT DISPERSION FROM INTRAOCULAR LENSES
- •UVEITIS-GLAUCOMA-HYPHEMA SYNDROME
- •GLAUCOMA FROM VITREOUS IN THE ANTERIOR CHAMBER
- •GLAUCOMA AFTER TRAUMA
- •CHEMICAL BURNS
- •ELECTRIC SHOCK
- •RADIATION
- •PENETRATING INJURIES
- •CONTUSION INJURIES
- •GLAUCOMA ASSOCIATED WITH INTRAOCULAR HEMORRHAGE
- •GHOST-CELL GLAUCOMA
- •HEMOLYTIC GLAUCOMA
- •HEMOSIDEROSIS
- •HYPHEMA
- •RETINAL DETACHMENT AND GLAUCOMA
- •SCHWARTZ SYNDROME
- •GLAUCOMA AFTER VITRECTOMY
- •GLAUCOMA WITH UVEITIS
- •FUCHS’ HETEROCHROMIC IRIDOCYCLITIS
- •GLAUCOMATOCYCLITIC CRISIS
- •HERPES SIMPLEX
- •HERPES ZOSTER
- •SARCOIDOSIS
- •JUVENILE RHEUMATOID ARTHRITIS
- •SYPHILIS
- •INTRAOCULAR TUMORS AND GLAUCOMA
- •AMYLOIDOSIS
- •ELEVATED EPISCLERAL VENOUS PRESSURE
- •SUPERIOR VENA CAVA OBSTRUCTIONS
- •THYROID EYE DISEASE
- •ARTERIOVENOUS FISTULAS
- •STURGE-WEBER SYNDROME
- •IDIOPATHIC ELEVATIONS
- •REFERENCES
- •TERMINOLOGY
- •CLASSIFICATION
- •SYNDROME CLASSIFICATION
- •PRIMARY GLAUCOMA
- •CLINICAL ANATOMIC CLASSIFICATION
- •Isolated trabeculodysgenesis
- •Iridodysgenesis
- •Anterior stromal defects
- •Structural iris defects
- •Corneodysgenesis
- •CLINICAL PRESENTATION
- •EXAMINATION
- •Office examination
- •Examination under anesthesia
- •Intraocular pressure measurement
- •Corneal measurements: diameter and central thickness
- •Axial length measurement
- •Gonioscopy
- •Ophthalmoscopy
- •Cycloplegic refraction
- •Systemic evaluation
- •PRIMARY CONGENITAL GLAUCOMA
- •INCIDENCE
- •GENETICS AND HEREDITY
- •PATHOPHYSIOLOGY
- •DIFFERENTIAL DIAGNOSIS
- •Other glaucomas
- •Other causes of corneal enlargement or clouding
- •Other causes of epiphora or photophobia
- •Other optic nerve abnormalities
- •MANAGEMENT
- •Preoperative management
- •Initial surgery
- •Follow-up evaluations
- •Filtering surgery
- •Synthetic drainage devices
- •Cyclodestructive procedures
- •Long-term follow-up, management, and prognosis
- •Late developing primary congenital glaucoma
- •GLAUCOMA ASSOCIATED WITH OTHER CONGENITAL ANOMALIES
- •FAMILIAL HYPOPLASIA OF THE IRIS WITH GLAUCOMA
- •DEVELOPMENTAL GLAUCOMA WITH ANOMALOUS SUPERFICIAL IRIS VESSELS
- •ANIRIDIA
- •STURGE-WEBER SYNDROME (ENCEPHALOFACIAL ANGIOMATOSIS, ENCEPHALOTRIGEMINAL ANGIOMATOSIS)
- •NEUROFIBROMATOSIS (VON RECKLINGHAUSEN’S DISEASE)
- •PIERRE ROBIN AND STICKLER SYNDROMES
- •SKELETAL DYSPLASTIC SYNDROMES
- •CORNEODYSGENESIS
- •Axenfeld’s anomaly
- •Rieger’s anomaly and syndrome
- •PETER’S ANOMALY
- •LOWE SYNDROME (OCULOCEREBRORENAL SYNDROME)
- •MICROCORNEA SYNDROMES
- •RUBELLA
- •CHROMOSOME ABNORMALITIES
- •BROAD THUMB SYNDROME (RUBENSTEIN–TAYBI SYNDROME)
- •SECONDARY GLAUCOMA IN INFANTS
- •PERSISTENT FETAL VASCULATURE (PERSISTENT HYPERPLASITIC PRIMARY VITREOUS)
- •RETINOPATHY OF PREMATURITY (RETROLENTAL FIBROPLASIAS)
- •LENS-RELATED GLAUCOMAS
- •Aphakic pediatric glaucoma
- •Subluxation and pupillary block
- •Marfan syndrome
- •Homocystinuria
- •Spherophakia and pupillary block
- •Weill-Marchesani and GEMSS syndromes
- •TUMORS
- •Retinoblastoma
- •Juvenile xanthogranuloma
- •INFLAMMATION
- •Juvenile rheumatoid arthritis
- •STEROID GLAUCOMA IN CHILDREN
- •NEOVASCULAR GLAUCOMA
- •TRAUMA
- •REFERENCES
- •Genetics of glaucoma
- •BASIC GENETICS
- •GENETIC NOMENCLATURE
- •PRIMARY OPEN-ANGLE, NORMAL-TENSION, AND JUVENILE-ONSET OPEN-ANGLE GLAUCOMA
- •TIGR/MYOCILIN
- •OPTINEURIN
- •OTHER GENES IN OPEN-ANGLE GLAUCOMA
- •EXFOLIATION SYNDROME AND GLAUCOMA
- •GLAUCOMA ASSOCIATED WITH DEVELOPMENTAL DISORDERS
- •PRIMARY CONGENITAL GLAUCOMA
- •AXENFELD-RIEGER ANOMALY
- •ANIRIDIA
- •NAIL PATELLA SYNDROME
- •RENAL TUBULAR ACIDOSIS
- •SUMMARY
- •REFERENCES
- •DIAGNOSIS
- •IDENTIFYING GLAUCOMA SUSPECTS
- •DETERMINING ADEQUACY OF TREATMENT
- •TREATMENT FOLLOW-UP
- •DOCUMENTATION OF PROGRESS
- •PATIENT EDUCATION
- •EFFECTIVE JUDGMENT
- •REFERENCES
- •TARGET PRESSURE
- •MEDICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •SURGICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •BASIC PHARMACOLOGY
- •BIOAVAILABILITY OF TOPICAL OCULAR MEDICATION
- •TEAR FILM
- •CORNEAL BARRIERS
- •DRUG FORMULATION
- •DRUG ELIMINATION
- •COMPLIANCE
- •GENERAL SUGGESTIONS FOR MEDICAL TREATMENT OF GLAUCOMA
- •ESTABLISH A TARGET PRESSURE
- •ADJUST THE TREATMENT PROGRAM TO THE PATIENT AND HIS OR HER LIFESTYLE
- •WHEN THERAPY IS INEFFECTIVE, SUBSTITUTE RATHER THAN ADD DRUGS
- •CONTINUALLY MONITOR THE TARGET PRESSURE
- •ASK ABOUT AND MONITOR OCULAR AND SYSTEMIC SIDE EFFECTS
- •SIMPLIFY AND REDUCE TREATMENT WHEN POSSIBLE
- •TEACH PATIENTS THE PROPER TECHNIQUE FOR INSTILLING EYEDROPS
- •PROVIDE WRITTEN INSTRUCTIONS
- •COMMUNICATE WITH THE PATIENT’S FAMILY PHYSICIAN
- •ASK ABOUT PROBLEMS WITH THE MEDICAL REGIMEN
- •CONSIDER DEFAULTING AS AN EXPLANATION FOR THE FAILURE OF MEDICAL TREATMENT
- •EDUCATE PATIENTS ABOUT THEIR ILLNESS AND ITS TREATMENT
- •STOP TREATMENT PERIODICALLY TO DETERMINE CONTINUING EFFECTIVENESS
- •MEASURE INTRAOCULAR PRESSURE AT DIFFERENT TIMES OF THE DAY AND AT DIFFERENT INTERVALS AFTER THE LAST ADMINISTRATION OF MEDICATION
- •RECOMMEND COMPARISON SHOPPING FOR MEDICATIONS
- •SUMMARY
- •REFERENCES
- •Prostaglandins
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •LATANOPROST (XALATAN, PHXA41)
- •BIMATOPROST
- •TRAVOPROST
- •FIXED COMBINATION AGENTS
- •SIDE EFFECTS
- •SUGGESTIONS FOR USE
- •REFERENCES
- •MECHANISM(S) OF ACTION
- •EPINEPHRINE
- •DIPIVEFRIN
- •NOREPINEPHRINE
- •Phenylephrine
- •Clonidine
- •Apraclonidine
- •Brimonidine
- •Isoproterenol
- •Salbutamol
- •Others
- •DOPAMINERGIC AGONISTS
- •ADRENERGIC POTENTIATORS
- •MONOAMINE OXIDASE AND CATECHOL O-METHYLTRANSFERASE INHIBITORS
- •6-HYDROXYDOPAMINE
- •PROTRIPTYLINE
- •GUANETHIDINE (ISMELIN)
- •NONADRENERGIC ACTIVATORS OF ADENYLATE CYCLASE
- •DRUGS IN CLINICAL USE
- •Epinephrine (Eppy, Epinal, Epifrin, and generics)
- •Dipivefrin (Propine and generics)
- •Suggestions for use
- •Side effects
- •Clonidine
- •Prophylaxis in anterior segment laser surgery
- •Argon laser trabeculoplasty
- •Laser iridotomy
- •Nd:YAG laser posterior capsulotomy
- •Management of acute pressure rises
- •Management of open-angle and other chronic glaucomas
- •Combination therapy
- •Side effects
- •Suggestions for use
- •SUMMARY
- •REFERENCES
- •Adrenergic antagonists
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •TIMOLOL MALEATE
- •TIMOLOL HEMIHYDRATE
- •BETAXOLOL
- •LEVOBUNOLOL
- •CARTEOLOL
- •METIPRANOLOL
- •PROPRANOLOL
- •ATENOLOL
- •PINDOLOL
- •NADOLOL
- •METAPROLOL
- •LABETOLOL
- •SUGGESTIONS FOR USE
- •OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •GLAUCOMA IN CHILDREN
- •BLOOD FLOW AND NEUROPROTECTION
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •OTHER ADRENERGIC ANTAGONISTS
- •Thymoxamine
- •Dapiprazole
- •Bunazosin
- •Prazosin
- •Others
- •REFERENCES
- •Carbonic anhydrase inhibitors
- •MECHANISM OF ACTION
- •DIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •INDIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •DRUGS IN CLINICAL USE
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •Dorzolamide
- •Brinzolamide
- •SYSTEMIC CARBONIC ANHYDRASE INHIBITORS
- •Acetazolamide
- •Methazolamide
- •Ethoxzolamide
- •Dichlorphenamide
- •SIDE EFFECTS
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •ORAL CARBONIC ANHYDRASE INHIBITORS
- •CONTRAINDICATIONS
- •Acidosis and sickling of red blood cells
- •Other severe symptoms
- •Retinal-choroidal blood flow and neuroprotection
- •SUGGESTIONS FOR USE
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •SECONDARY GLAUCOMA
- •INFANTILE AND JUVENILE GLAUCOMA
- •OTHER USES
- •REFERENCES
- •Cholinergic drugs
- •MECHANISMS OF ACTION
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •DRUGS IN CLINICAL USE
- •DIRECT-ACTING CHOLINERGIC AGENTS
- •Acetylcholine
- •Pilocarpine
- •Alternative drug delivery systems
- •Methacholine (Mecholyl)
- •Carbachol
- •Aceclidine (Glaucostat)
- •INDIRECT (ANTICHOLINESTERASE) AGENTS
- •Echothiophate iodide (phospholine iodide)
- •Demecarium bromide (Humorsol, Tosmilen)
- •Isoflurophate (Floropryl, di-isopropyl fluorophosphate, Dyflos)
- •Physostigmine (eserine)
- •Neostigmine (prostigmine)
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •SUGGESTIONS FOR USE
- •EXAMINATION
- •CONTRAINDICATIONS
- •REFERENCES
- •Hyperosmotic agents
- •MECHANISMS OF ACTION
- •DRUGS IN CLINICAL USE
- •ORAL AGENTS
- •Glycerol
- •Isosorbide
- •Ethyl alcohol
- •INTRAVENOUS AGENTS
- •Mannitol
- •Urea
- •SIDE EFFECTS
- •SUGGESTIONS FOR CLINICAL USE
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •CILIARY BLOCK (MALIGNANT) GLAUCOMA
- •TOPICAL HYPEROSMOTIC AGENTS
- •OTHER
- •REFERENCES
- •General aspects of laser therapy
- •GENERAL ASPECTS OF LASER THERAPY
- •TISSUE EFFECTS OF LASER
- •THERMAL EFFECTS (PHOTOCOAGULATION, PHOTOVAPORIZATION)
- •PHOTODISRUPTION
- •PHOTOABLATION
- •PHOTOCHEMICAL EFFECTS
- •GENERAL PREPARATION OF THE PATIENT
- •BASIC LASER SAFETY
- •REFERENCES
- •LASER PERIPHERAL IRIDOTOMY
- •INDICATIONS
- •TYPES OF LASER
- •GENERAL PREPARATION
- •ND:YAG LASER IRIDOTOMY
- •ARGON OR SOLID-STATE LASER IRIDOTOMY
- •LIGHT BROWN IRIS
- •Dark brown iris
- •Light blue iris
- •COMPLICATIONS OF LASER IRIDOTOMY
- •Iritis
- •Pressure elevation
- •Cataract
- •Hyphema
- •Corneal epithelial injury
- •Endothelial damage
- •Corneal stroma
- •Failure to perforate
- •Late closure
- •Retinal burn
- •Aphakia and pseudophakia with pupillary block
- •LASER IRIDOPLASTY (GONIOPLASTY)
- •PLATEAU IRIS
- •NANOPHTHALMOS
- •LASERS IN MALIGNANT GLAUCOMA
- •REFERENCES
- •LASER TRABECULOPLASTY
- •HISTORY
- •RESULTS
- •SELECTIVE LASER TRABECULOPLASTY
- •Concept
- •Mechanism
- •Technique
- •Patient preparation
- •Procedure
- •POSTOPERATIVE TREATMENT
- •OUTCOMES
- •CONTRAINDICATIONS
- •AS INITIAL THERAPY
- •PREDICTORS OF OUTCOME
- •APHAKIC AND PSEUDOPHAKIC OPEN-ANGLE GLAUCOMA
- •COMPLICATIONS
- •Intraocular pressure elevation
- •Sustained intraocular pressure increase
- •Hyphema
- •Peripheral anterior synechiae
- •Iritis
- •Uveitis
- •EXCIMER LASER TRABECULOSTOMY
- •Concept
- •Technique
- •Outcomes
- •OTHER LASER SCLEROSTOMY TECHNIQUES
- •REFERENCES
- •CYCLOPHOTOCOAGULATION
- •OTHER LASER PROCEDURES
- •SEVERING OF SUTURES
- •REOPENING FAILED FILTRATION SITES
- •CYCLODIALYSIS AND LASER
- •LASER SYNECHIALYSIS
- •GONIOPHOTOCOAGULATION
- •PHOTOMYDRIASIS (PUPILLOPLASTY)
- •REFERENCES
- •General surgical care
- •THE SURGICAL DECISION
- •PREOPERATIVE CARE
- •INSTRUCTIONS TO THE PATIENT
- •OUTPATIENT VERSUS INPATIENT SURGERY
- •PREOPERATIVE MEDICATIONS
- •OPERATIVE CARE
- •THE OPERATING ROOM
- •ANESTHESIA
- •EQUIPMENT
- •POSTOPERATIVE CARE
- •ACTIVITY
- •MEDICATIONS
- •REFERENCES
- •Glaucoma outflow procedures
- •GENERAL CONSIDERATIONS
- •EXTERNAL FILTRATION SURGERY
- •GUARDED PROCEDURES
- •FULL-THICKNESS PROCEDURES
- •RESULTS OF EXTERNAL FILTRATION SURGERY
- •THE CONJUNCTIVAL FLAP
- •LIMBUS-BASED FLAP
- •FORNIX-BASED FLAP
- •EXCISION OF TENON’S CAPSULE
- •GUARDED FILTRATION PROCEDURE
- •TRABECULECTOMY
- •Indications
- •Standard technique
- •Moorfields Safer Surgery System technique
- •Results
- •Surgical options and modifications
- •Triangular versus rectangular flap
- •Postoperative lasering, adjustment, or release of sutures
- •Wound-healing retardants
- •FULL-THICKNESS FILTRATION PROCEDURES
- •THERMAL SCLEROSTOMY (SCHEIE PROCEDURE)
- •SCLERECTOMY
- •Posterior lip sclerectomy
- •Anterior lip sclerectomy
- •TREPHINATION
- •IRIDENCLEISIS
- •GLAUCOMA DRAINAGE DEVICES
- •THE MOLTENO IMPLANT
- •Techniques
- •SCHOCKET PROCEDURE
- •KRUPIN VALVE AND EX-PRESS IMPLANT
- •AHMED VALVE
- •BAERVELDT IMPLANT
- •RESULTS AND COMPLICATIONS OF DRAINAGE DEVICES
- •REFERENCES
- •CATARACT SURGERY IN THE GLAUCOMATOUS EYE
- •TYPES OF GLAUCOMA AND THEIR INFLUENCE ON CATARACT MANAGEMENT
- •SELECTING THE APPROPRIATE SURGICAL APPROACH
- •SELECTING THE APPROPRIATE PROCEDURE: HISTORICAL CONSIDERATIONS
- •SURGICAL TECHNIQUES FOR COMBINED PROCEDURES
- •GENERAL PREOPERATIVE CONSIDERATIONS
- •SMALL-INCISION COMBINED SURGERY
- •Incision sites
- •Fornix versus limbal conjunctival flap
- •Scleral flap
- •Antimetabolite use
- •Managing the small pupil
- •Phacoemulsification techniques
- •Intraocular lens selection
- •Trabeculectomy formation
- •Flap closure
- •Postoperative medical management
- •EXTRACAPSULAR CATARACT EXTRACTION COMBINED SURGERY
- •Miotic pupil
- •Incision construction
- •CATARACT SURGERY WITH PRE-EXISTING FILTRATION BLEB
- •REFERENCES
- •BUTTONHOLING THE CONJUNCTIVA
- •THE SHALLOW AND FLAT ANTERIOR CHAMBER
- •FLAT ANTERIOR CHAMBER WITH HYPOTONY
- •FLAT ANTERIOR CHAMBER IN NORMOTENSIVE AND HYPERTENSIVE EYES
- •CILIARY BLOCK (MALIGNANT GLAUCOMA)
- •SUPRACHOROIDAL HEMORRHAGE (SCH)
- •INTRAOPERATIVE FLAT ANTERIOR CHAMBER
- •HYPHEMA
- •LARGE HYPHEMA
- •INTRAOCULAR INFECTION
- •SYMPATHETIC OPHTHALMIA
- •FILTRATION FAILURE
- •DIGITAL PRESSURE
- •FAILURE DURING THE FIRST POSTOPERATIVE WEEK
- •PLUGGED SCLEROSTOMY SITE
- •RETAINED VISCOELASTIC MATERIAL
- •TIGHT SCLERAL FLAP: RELEASABLE SUTURES AND LASER SUTURE LYSIS
- •INADEQUATE OPENING OF DESCEMET’S MEMBRANE
- •ENCAPSULATED BLEB
- •REOPERATION AFTER FAILED FILTRATION
- •REVISION OF ENCYSTED BLEB
- •Needling of failed blebs
- •Slit-lamp or minor surgery setting
- •Operating room setting
- •FAILED FILTRATION WITH NO BLEB
- •BLEB COMPLICATIONS AND MANAGEMENT
- •THIN-WALLED BLEBS
- •DIFFUSE BLEBS
- •OVERFUNCTIONING BLEBS
- •DELLEN
- •HYPOTONOUS MACULOPATHY
- •LATE HYPOTONY AFTER FILTERING SURGERY
- •HYPOTONY WITH OCCULT FILTERING ‘BLEB’
- •HYPOTONY WITH OCCULT CYCLODIALYSIS CLEFTS
- •HYPOTONY WITH AQUEOUS SUPPRESSION THERAPY IN CONTRALATERAL EYE
- •HYPOTONY FROM RETINAL DETACHMENT
- •HYPOTONY FROM IRITIS OR ISCHEMIA
- •REFERENCES
- •SURGERY FOR INFANTILE AND JUVENILE GLAUCOMA
- •GONIOTOMY
- •Preoperative considerations
- •Intraoperative procedures
- •Complications
- •Practice goniotomy
- •Other ab-interno angle surgery
- •TRABECULOTOMY AB EXTERNO
- •EVALUATION OF GONIOTOMY AND TRABECULOTOMY
- •COMBINED TRABECULOTOMY AND TRABECULECTOMY
- •TRABECULODIALYSIS
- •MISCELLANEOUS PROCEDURES
- •Goniosynechialysis
- •Cyclocryotherapy
- •Retrobulbar alcohol injection
- •Earlier procedures
- •REFERENCES
- •New ideas in glaucoma surgery
- •INTRODUCTION
- •NON-PENETRATING GLAUCOMA SURGERY
- •VISCOCANALOSTOMY
- •BYPASS INTRASCLERAL CHANNELS (NON-PENETRATING DEEP SCLERECTOMY)
- •SHUNTS INTO SCHLEMM’S CANAL
- •TRABECTOME®
- •SHUNTS INTO THE SUPRACHOROIDAL SPACE
- •SUMMARY
- •REFERENCES
- •Challenges for the new century
- •PATHOPHYSIOLOGY
- •CLASSIFICATION AND DIAGNOSIS
- •SCREENING
- •TREATMENT
- •CONCLUSION
- •REFERENCES
- •Appendix
- •GLAUCOMA CONSENSUS
- •GLAUCOMA DIAGNOSIS – STRUCTURE AND FUNCTION (2004)
- •CONSENSUS STATEMENTS
- •Structure
- •Function
- •Function and structure
- •GLAUCOMA SURGERY – OPEN ANGLE GLAUCOMA (2005)
- •CONSENSUS STATEMENTS
- •Indications for glaucoma surgery
- •Argon laser trabeculoplasty
- •Wound healing
- •Trabeculectomy
- •Combined cataract/trabeculectomy
- •Aqueous shunting procedures with glaucoma drainage devices
- •Comparison of procedures: trabeculectomy versus aqueous shunting procedures with glaucoma drainage devices
- •Non-penetrating glaucoma drainage surgery
- •Comparison of trabeculectomy with non-penetrating drainage glaucoma surgery in open-angle glaucoma
- •Cyclodestruction
- •Comparison of cyclophotocoagulation and glaucoma drainage device implantation
- •ANGLE CLOSURE AND ANGLE-CLOSURE GLAUCOMA (2006)
- •CONSENSUS STATEMENTS
- •Management of acute angle closure crisis
- •Surgical management of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Detection of primary angle closure and angle-closure glaucoma
- •INTRAOCULAR PRESSURE (2007)
- •CONSENSUS STATEMENTS
- •Measurement of intraocular pressure
- •Intraocular pressure as a risk factor for glaucoma development & progression
- •Epidemiology of intraocular pressure
- •Clinical trials and intraocular pressure
- •Target intraocular pressure in clinical practice
- •Index
|
chapter |
Aqueous humor formation |
2 |
|
|
are ineffective topically and must be administered systemically or intravitreally, which is not clinically feasible. Vanadate, an inhibitor of Na -K ATPase, reduces aqueous humor formation and IOP
in rabbits and monkeys, but this drug appears to act by a mechanism distinct from its effect on this enzyme.248–250 A variety of other
drugs, including sedatives, anesthetic agents, and hormones, depress aqueous humor production.251,252
Surgery
A number of surgical procedures, including cyclocryotherapy and cyclodiathermy, reduce aqueous humor formation (see Table 2-5). It is not clear whether these procedures act on the ciliary epithelium or the ciliary body vasculature. There is considerable controversy about whether cyclodialysis decreases aqueous humor flow.69,165
References
1. Seidel E:Weitere experimentelle untersuchengen uber die quelle und den verlauf der intraokularen saftstromung. IX Mitterlung uber den abfluss des kammerwasser aus der vorderen augenkammers, Graefes Arch 104:537, 1921.
2. Seidel E:Weitere experimentelle untersuchengen uber die quelle und den verlauf der intraokularen saftstromung. XII Mitterlung uber den manometrischen nachweis des physiologeschen druckgefalles zwischen vorderkammer und Schlemmscher kanal, Graefes Arch 107:101, 1921.
3. Ascher KW:The aqueous veins. I. Physiological importance of the visible elimination of intra-ocular fluid,Am J Ophthalmol 25:1174, 1942.
4. Ashton N:Anatomical study of Schlemm’s canal and aqueous veins by means of neoprene casts: part I. Aqueous veins, Br J Ophthalmol 35:921, 1951.
5. Reddy DVN: Dynamics of transport systems in the eye, Invest OphthalmolVis Sci 18:1000, 1979.
6. Cole DF:Aqueous humor formation, Doc Ophthalmol 21:116, 1965.
7. Cole DF: Secretion of aqueous humor, Exp Eye Res 25(suppl):161, 1977.
8. Brubaker RF: Goldmann’s equation and clinical measures of aqueous dynamics, Exper Eye Res 78:633, 2004.
9. Rohen JW, Futa R, Lütjen-Drecoll E:The fine structure of the cribiform meshwork in normal and glaucomatous eyes as seen in tangential sections,
Invest OphthalmolVis Sci 21:574, 1981.
10.Hogan MJ,Alvarado JA,Weddell JE: Histology of the human eye: an atlas textbook, Philadelphia,WB Saunders, 1971.
11.Brubaker RF, et al:The effect of age on aqueous humor formation in man, Ophthalmology 88:283, 1981.
12.Bauermann M: Uber das Ciliafortsatzgeffassystem, Ber Zusammen Kunft Dtsch Opthal Ges 48:364, 1930.
13.Smelser GK: Electron microscopy of a typical epithelial cell and of the normal human ciliary process,Trans Am Acad Ophthalmol Otolaryngol 70:738, 1966.
14.Lütjen-Drecoll E, Lonnerholm G, Eichhorn M: Carbonic anhydrase distribution in the human and monkey eye by light and electron microscopy, Graefes Arch Clin Exp Ophthalmol 220:285, 1983.
15.Tormey JM:The ciliary epithelium: an attempt to correlate structure and function,Trans Am Acad Ophthalmol Otolaryngol 70:755, 1966.
16.Fujita H, Konko K, Sears M: Eine neue funktion der nicht pigmentierten epithels der ziliarkorperfortsatze bei der kammerwasserproduktion, Klin Mbl Augenheilk 185:28, 1984.
17.Hara K, et al: Structural differences between regions of the ciliary body of primates, Invest Ophthalmol Vis Sci 16:912, 1977.
18.Ober M, Rohen JW: Regional differences in the fine structure of the ciliary epithelium related to accommodation, Invest OphthalmolVis Sci 18:655, 1979.
19.Raviola G, Raviola E: Intercellular injections in the ciliary epithelium, Invest OphthalmolVis Sci 17:958, 1978.
20.Oh J, et al: Dye coupling of rabbit ciliary epithelial cells in vitro, Invest OphthalmolVis Sci 35:2509, 1994.
21.Bukauskas FF, Peraccchia C:Two distinct gating
mechanisms in gap junction channels: CO2-sensitive and voltage-sensitive, Biophys J 71:2137, 1997.
22.To C, et al:The mechanism of aqueous humour formation, Clin Exper Optom 85:335, 2002.
23.Calera MR, et al: Connexin43 is required for production of the aqueous humor in the murine eye, J Cell Sci 119(Pt 21):4510, 2006.
24.Bairati A, Orzalesi N:The ultrastructure of the epithelium of the ciliary body: a study of the function complexes and of the changes associated with the production of plasmoid aqueous humor, Z Zellforsch Mikrosk Anat 69:635, 1966.
25.Cole DF: Location of ouabain-sensitive adenosinetriphosphatase in ciliary epithelium, Exp Eye Res 3:72, 1964.
26.ShioseY: Electron microscopic studies on blood retinal and blood–aqueous barriers, Jpn J Ophthalmol 14:73, 1970.
27.Smith RS: Ultrastructural studies of the blood aqueous barrier. I.Transport of an electron-dense tracer in the iris and ciliary body of the mouse,Am J Ophthalmol 71:1066, 1971.
28.Smith RS, Rudt LA: Ultrastructural studies of the blood aqueous barrier. II.The barrier to horseradish peroxidase in primates,Am J Ophthalmol 76:937, 1973.
29.Smith RS, Rudt LA: Ocular, vascular and epithelial barriers to microperoxidase, Invest OphthalmolVis Sci 14:556, 1975.
30.Ustitalo R, Palkama A: Localization of sodiumpotassium stimulated adenosine triphosphatase activity in the rabbit ciliary body using light and electron microscopy,Ann Exp Fenn 48:84, 1970.
31.Vegge T:An epithelial blood–aqueous barrier to horseradish peroxidase in the processes of the vervet monkey Ceropithecus aethips, Z Zellforsch Mikrosk Anat 114:309, 1971.
32.McLaughlin CW, et al: Regional differences in ciliary epithelial cell transport properties, J Membr Biol 182(3):213, 2001.
33.Mizuno K,Asoka M: Cycloscopy and fluorescein cycloscopy, Invest Ophthalmol 15:561, 1976.
34.Russmann W: Levels of glycolytic enzyme activity in the ciliary epithelium prepared from bovine eyes, Ophthalmic Res 2:205, 1971.
35.Feeney L, Mixon R: Localization of 35 sulfated macromolecules at the site of active transport in the ciliary processes, Invest Ophthalmol 13:882, 1974.
36.Feeney L, Mixon R: Sulfate and galactose metabolism in differentiating ciliary body and iris epithelia: autoradiographic and ultrastructural studies, Invest Ophthalmol 14:364, 1975.
37.Ruskell GL: Innervation of the anterior segment of the eye. In: Lütjen-Drecoll E, editor: Basic aspects of glaucoma research, Stuttgart, Schattauer, 1982.
38.Bloom JN, et al: Cholinergic and adrenergic receptors in freshly isolated ciliary epithelium, Invest OphthalmolVis Sci 24(suppl):89, 1983.
39.Neufeld A, Bartels SP: Receptor mechanisms for epinephrine and timolol. In: Lütjen-Drecoll,
editor: Basic aspects of glaucoma research, Stuttgart, Schattauer, 1982.
40.Woodlief NF: Initial observations on the ocular microcirculation in man. I.The anterior segment and extraocular muscles,Arch Ophthalmol 98:1268, 1980.
41.Alm A, Bill A,Young FA:The effects of pilocarpine and neostigmine on the blood flow through the anterior uvea in monkeys: a study with radioactively labelled microspheres, Exp Eye Res 15:31, 1973.
42.Brubaker RF: Flow of aqueous humor in humans, Invest OphthalmolVis Sci 32:3145, 1991.
43.Alm A, Bill A:The oxygen supply to the retina. I. Effects of changes in intraocular and arterial blood
pressures, and in arterial PO2 and PCO2 on the oxygen tension in the vitreous body of the cat, Acta Physiol Scand 84:261, 1972.
44.Lindner K: Zur Untersuchung des Flussigkeitswechels in Auge, Dtsch Ophthalmol 42:33, 1920.
45.Bill A: Blood circulation and fluid dynamics in the eye, Physiol Rev 55:383, 1975.
46.Kiel. JW, Reitsamer HA: Relationship between ciliary blood flow and aqueous production: does it play a role in glaucoma therapy? J Glaucoma 15:172, 2006.
47.Reitsamer HA, Posey M, Kiel JW: Effects of a topical alpha2 adrenergic agonist on ciliary blood flow and aqueous production in rabbits, Exp Eye Res 82:405, 2006.
48.Bill A, Nilsson S:The blood supply of the eye and its regulation. In: Lütjen-Drecoll E, editor: Basic aspects of glaucoma research, Stuttgart, Schattauer, 1982.
49.Alm A, Bill A:The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats,Acta Physiol Scand 84:306, 1972.
50.Alm A, Bill A:The effect of stimulation of the cervical sympathetic chain on retinal oxygen tension and on uveal, retinal and cerebral blood flow in cats, Acta Physiol Scand 88:84, 1973.
51.Cole DF, Unger WG: Prostaglandins as mediators for the responses of the eye to trauma, Exp Eye Res 17:357, 1973.
52.Neufeld AH, Sears ML: Prostaglandin and eye, Prostaglandins 4:157, 1973.
53.Podos SM, Becker B, Kass MA: Prostaglandin synthesis, inhibition and intraocular pressure, Invest OphthalmolVis Sci 12:426, 1973.
54.Whitelock RAF, Eakins KE:Vascular changes in the anterior uvea of the rabbit produced by prostaglandins,Arch Ophthalmol 89:495, 1973.
55.Neufeld AH, Jampol LM, Sears ML:Aspirin prevents the disruption of the blood aqueous barrier in the rabbit eye, Nature 238:158, 1972.
56.Perkins ES, Unger WG, Bass M:The role of prostaglandin in the ocular responses to laser irradiation of the iris, Exp Eye Res 17:394, 1973.
57.Bill A:Autonomic nervous control of uveal blood flow,Acta Physiol Scand 56:70, 1962.
58.Langham ME, Rosenthal AR:The role of cervical sympathetic nerve in regulation of the intraocular pressure and circulation, J Physiol 210:786, 1966.
59.Langham ME,Taylor CB:The influence of superior cervical ganglionectomy on intraocular dynamics, J Physiol 152:447, 1960.
60.Davson H: Physiology of the ocular and cerebrospinal fluids, London, J & A Churchill, 1956.
61.Bill A: Capillary permeability to and extravascular dynamics of myoglobin, albumin and gamma globulin in the uvea,Acta Physiol Scand 73:204, 1968.
62.Allansmith M, Newman L,Whitney C:The distribution of immunoglobulin in the rabbit eye, Arch Ophthalmol 86:60, 1971.
63.Allansmith MR, et al: Immunoglobulins in the human eye. Location, type and amount,Arch Ophthalmol 89:36, 1973.
64.Bill A:A method to determine osmotically effective albumin and gamma globulin concentrations in tissue
21
part
2 Aqueous humor dynamics
fluids, its application to the uvea and a note on the effects of capillary ‘leaks’ on tissue fluid dynamics, Acta Physiol Scand 73:511, 1968.
65.Green K, Pederson E: Contribution of secretion and filtration to aqueous humor formation,Am J Physiol 222:1218, 1972.
66.Pederson JE, Green K:Aqueous humor dynamics: a mathematical approach to measurement of facility, pseudofacility, capillary pressure, active secretion and Xc, Exp Eye Res 15:265, 1973.
67.Pederson JE, Green K:Aqueous humor dynamics: experimental studies, Exp Eye Res 15:277, 1973.
68.Weinbaum S, Langham ME, Goldgrabben JR:The role of secretion and pressure-dependent flow in aqueous humor formation, Exp Eye Res 13:266, 1972.
69.Brubaker RF:The physiology of aqueous humor formation. In: Drance SM, Neufeld AH, editors: Glaucoma: applied pharmacology in medical treatment, NewYork, Grune & Stratton, 1984.
70.Curran PF, Macintosh JR:A model system for biological water transport, Nature 193:347, 1962.
71.Diamond JM, Bossert WH: Standing-gradient osmotic flow, J Gen Physiol 50:2061, 1967.
72.Civan M, MacKnight ADC:The ins and outs of aqueous humor secretion, Exp Eye Research 78:625, 2004.
73.Kishida S, et al: Electric characteristics of ciliary body, Jpn J Ophthalmol 25:407, 1981.
74.Krupin T, et al:Transepithelial electrical measurements on isolated rabbit iris-ciliary body, Invest OphthalmolVis Sci 22(suppl):100, 1982.
75.Becker B: Ouabain and aqueous humor dynamics in the rabbit eye, Invest Ophthalmol 2:325, 1963.
76.Cole DF: Effects of some metabolic inhibitors upon the formation of the aqueous humour in rabbits, Br J Ophthalmol 44:739, 1960.
77.Maren TH: Ion secretion into the posterior aqueous humor of dogs and monkeys, Exp Eye Res 25(suppl):245, 1977.
78.Riley MV, Kishida K:ATPases of ciliary epithelium: cellular and subcellular distribution and probable role in secretion of aqueous humor, Exp Eye Res 42:559, 1986.
79.ShioseY, Sears ML: Localization and other aspects of the histochemistry of nucleoside phosphatase in the ciliary epithelium of albino rabbits, Invest Ophthalmol 4:64, 1965.
80.ShioseY, Sears ML: Fine structural localization of nucleoside phosphatase activity in the ciliary epithelium of albino rabbits, Invest Ophthalmol 5:152, 1966.
81.Usukura J, Fain GL, Bok D: [3 H]oubain localization of Na-K ATPase in the epithelium of rabbit ciliary body pars plicata, Invest OphthalmolVis Sci 29:606, 1988.
82.Simon KA, Bonting SL, Hawkins NM: Studies on sodium-potassium-activated adenosine
triphosphatase. II. Formation of aqueous humor, Exp Eye Res 1:253, 1962.
83.Krupin T, et al:Transepithelial electrical measurements on the isolated rabbit iris–ciliary body, Exp Eye Res 38:115, 1984.
84.Chu TC, Candia OA, Podos SM: Electrical parameters of the isolated monkey ciliary epithelium and effects of pharmacological agents, Invest OphthalmolVis Sci 28:1644, 1987.
85.Kishida K, et al: Sodium and chloride transport across the isolated rabbit ciliary body, Curr Eye Res 2:149, 1982.
86.Holland MG, Gipson CC: Chloride ion transport in the isolated ciliary body, Invest Ophthalmol 9:20, 1970.
87.To CH, et al: Chloride and sodium transport across bovine ciliary body epithelium, Curr Eye Res 17:896, 1998.
88.Candia OAS, Shi XP, Chu TC:Ascorbate stimulated active Na transport in rabbit ciliary epithelium, Curr Eye Res 10:197, 1991.
89.Kong CW, Li KK,To CH: Chloride secretion by porcine ciliary epithelium: new insight into species similarities and differences in aqueous humor formation, Invest OphthalmolVis Sci 47:5428, 2006.
90. Do CW, Civan MM: Swelling-activated chloride channels in aqueous humour formation: on the oneside and the other,Acta Physiol (Oxf) 187:345, 2006.
91. Gerometta RM, et al: Cl concentrations of bovine, porcine and ovine aqueous humor are higher than in plasma, Exp Eye Res 80(3):307, 2005.
92. Zimmerman TJ, et al:The effects of acetazolamide on the movement of sodium into the posterior chamber of the dog eye, J Pharmacol 199:510, 1976.
93. Dobbs PD, Epstein DL,Anderson PJ: Identification of isoenzyme C as the principal carbonic anhydrase in human ciliary processes, Invest OphthalmolVis Sci 18:867, 1979.
94. Kumpulainen T: Immunohistochemical demonstration of carbonic anhydrase isoenzyme C in the epithelium of the human ciliary processes, Histochemistry 77:281, 1983.
95. Sly WS, Hu PY: Human carbonic anhydrases and carbonic anhydrase deficiencies,Ann Rev Biochem 64:375, 1995.
96. Lindskog S: Structure and mechanism of carbonic anhydrae, Pharmacol Ther 74:1, 1997.
97. Maren TH, et al:The rates of ion movement from plasma to aqueous humor in the dogfish, Squalus acanthias, Invest Ophthalmol 14:662, 1975.
98. Krupin T, et al:Acidosis, alkalosis, and aqueous humor dynamics in rabbits, Invest OphthalmolVis Sci 16:997, 1977.
99. Cotlier E: Bicarbonate ATP-ase in ciliary body and a theory of Diamox effect on aqueous humour
production, Int Ophthalmol 1:123, 1979.
100.Holland MG: Chloride ion transport in the isolated ciliary body. II. Ion substitution experiments, Invest Ophthalmol 9:30, 1970.
101.Wiederholdt M, Helbig H, Korbmacher C: Ion transport across the ciliary epithelium: lessons from cultured cells and proposed role of the carbonic anhydrase. In: Botre F, Gross G, Storey BT, editors: Carbonic anhydrase, NewYork,VCH Weinheim, pp 232–244, 1991.
102.Matsui H, et al: Membrane carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes, Exp Eye Res 62:409, 1996.
103.Do CW,To CH: Chloride secretion by bovine cilicary epithelium: a model of aqueous humor formation, Invest OphthalmolVis Sci 41:1853, 2000.
104.Macknight AD, et al: Formation of the aqueous humor, Clin Exp Pharmacol Physiol 27:100, 2000.
105.Coca-Prados M, et al:Association of ClC channel with Cl transport by human nonpigmented ciliary epithelial cells, J Membr Biol 150:197, 1996.
106.Wang L, Chen L, Jacob TJ:The role of ClC-3 in volume-activated chloride currents and volume regulation in bovine epithelial cells demonstrated by antisense inhibition, J Physiol 524:63, 2000.
107.Dibas AI, Mia AJ,Yorio T:Aquaporins (water channels): role in vasopressin-activated water transport, Proc Soc Exp Biol Med 219:183, 1998.
108.Krupin TC, Civan MM: Physiologic basis of aqueous humor formation. In: Ritch R, Shields B, Krupin T, editors:The glaucomas, 2nd edn, St Louis, Mosby, pp 251–280, 1995.
109.Mead A, Sears J, Sears M:Transepithelial transport of ascorbic acid by the isolated intact ciliary epithelial bilayer of the rabbit eye, J Ocul Pharm Ther 12:253, 1996.
110.KinseyVE, Reddy DVN: Chemistry and dynamics of aqueous humor. In: Prince JH, editor:The rabbit in eye research, Springfield, Ill, Charles C Thomas, 1966.
111.Sen DK, Sarin GS, Saha K: Immunoglobulins in human aqueous humor, Br J Ophthalmol 61:216, 1977.
112.Bill A: Intraocular pressure and blood flow through the uvea,Arch Ophthalmol 67:336, 1962.
113.Bill A:The aqueous humor drainage mechanism in the cynomolgus monkey Macaca irus with evidence for unconventional routes, Invest Ophthalmol 4:911, 1965.
114.Bill A: Movement of albumin and dextran through the sclera,Arch Ophthalmol 74:248, 1965.
115.Bill A: Phillips CI: Uveoscleral drainage of aqueous humor in human eyes, Exp Eye Res 12:275, 1971.
116.Becker B:The transport of organic anions by the rabbit eye. I. In vitro iodopyracet (Diodrast)
accumulation by ciliary body-iris preparations,Am J Ophthalmol 50:862, 1960.
117.Bito LZ, Davson H, Salvador EV: Inhibition of in vitro concentrative prostaglandin accumulation by prostaglandins, prostaglandin analogues and by
some inhibitors of organic anion transport, J Physiol 256:257, 1976.
118.Bito LZ, Salvador EV: Intraocular fluid dynamics. II. Post mortem changes in solute concentrations, Exp Eye Res 10:273, 1970.
119.Becker B: Iodide transport by the rabbit eye,Am J Physiol 200:804, 1961.
120.Forbes M, Becker B:The transport of organic anions by the rabbit eye. II. In vitro transport of iodopyracet (Diodrast),Am J Ophthalmol 50:867, 1960.
121.Forbes M, Becker B:The transport of organic anions by the rabbit ciliary body. IV.Acetazolamide and rate of aqueous flow,Am J Ophthalmol 51:1047, 1961.
122.Barany EH: Inhibition by hippurate and probenecid of in vitro uptake of iodipamide and o-iodohippurate: a composite uptake system for iodipamide in choroid plexus, kidney cortex, and anterior uvea of several species,Acta Physiol Scand 86:12, 1972.
123.Barany EH:The liver-like anion transport system in rabbit kidney, uvea and choroid plexus. I. Selectivity of some inhibitors, direction of transport, possible physiological substrates,Acta Physiol Scand 88:412, 1973.
124.Barany EH:The liver-like anion transport system in rabbit kidney, uvea and choroid plexus. II. Efficiency of acidic drugs and other anions as inhibitors,Acta Physiol Scand 88:491, 1973.
125.Bito LZ, Salvador EV: Intraocular fluid dynamics. III.The site and mechanism of prostaglandin transfer across the blood intra-ocular fluid barriers, Exp Eye Res 14:233, 1972.
126.Bito LZ,Wallenstein MC, Baroody R:The role of transport processes in the distribution and disposition of prostaglandins. In: Samuelsson B,
Paoletti R, editors: Prostaglandins and thromboxane research, vol 1, NewYork, Lippincott-Raven, 1976.
127.Becker B:The effect of hypothermia on aqueous humor dynamics. III.Turnover of ascorbate and sodium,Am J Ophthalmol 51:1032, 1961.
128.Berggren L: Effect of composition of medium and of metabolic inhibitors on secretion in vitro by the ciliary processes of the rabbit eye, Invest Ophthalmol 4:83, 1965.
129.Bonting SL, Becker B: Studies on sodiumpotassium activated adenosinetriphosphatase. XIV. Inhibition of enzyme activity and aqueous humor flow in the rabbit eye after injection of ouabain, Invest Ophthalmol 3:523, 1964.
130.Cole DF: Some effects of decreased plasma sodium concentration on the composition and tension of the aqueous humor, Br J Ophthalmol 43:268, 1959.
131.Bito LZ, Davson H: Steady-state concentrations of potassium in the ocular fluids, Exp Eye Res 3:283, 1964.
132.Becker B: Chemical composition of human aqueous humor: effects of acetazolamide,Arch Ophthalmol 57:793, 1957.
133.Dickinson JC, Durham DC, Hamilton PB: Ion exchange chromatography of free amino acids in aqueous fluid and lens of the human eye, Invest Ophthalmol 7:551, 1968.
134.de Berardinis E, et al:The chemical composition of the human aqueous humour in normal and pathological conditions, Exp Eye Res 4:179, 1965.
135.Poos F: Uber den histologischen und klinischen Erscheinungen bei akuten lokalen
Capillarkreislaufstorungen am Auge, Graefes Arch 127:489, 1931.
136.Raviola G: Structural basis of the blood-ocular barriers, Exp Eye Res 25(suppl):27, 1977.
137.Eakins KE: Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier, Exp Eye Res 25(suppl):483, 1977.
22
|
chapter |
Aqueous humor formation |
2 |
|
|
138.Greeff R: Befund am Corpus Ciliare nacht Punktion der vorderen Kammer: ein beitrag zur Lehre vom Flussigkeitswechsel im Auge und der Fibrinbildung im Kammerwasser,Arch Augenheilk 28:178, 1894.
139.Rohen J: Morphologische Beitrage zum Problem der Kammerwasserbildung. I. Die Gestalt der Blutkammerwasserschranke beim Kaninchen in Ruhe und nacht funktioneller Belastung, Ber Dtsch Ophthalmol Gest 58:65, 1953.
140.Okisaka S: Effects of paracentesis on the bloodaqueous barrier: a light and electron microscopic study on the cynomolgus monkey, Invest Ophthalmol 15:824, 1976.
141.Raviola G: Effects of paracentesis on the bloodaqueous barrier: an electron microscope study on Macaca mulatta using horseradish peroxidase as a tracer, Invest Ophthalmol 13:828, 1974.
142.Bloom JN, et al: Fluorophotometry and the rate of aqueous flow in man. I. Instrumentation and normal values,Arch Ophthalmol 94:435, 1976.
143.Coakes RL, Brubaker RF: Method of measuring aqueous humor flow and corneal endothelial permeability using a fluorophotometry nomogram, Invest OphthalmolVis Sci 18:288, 1979.
144.Grant WM:A tonographic method for measuring the facility and rate of aqueous flow in human eyes, Arch Ophthalmol 44:204, 1950.
145.Grant WM: Clinical measurements of aqueous outflow,Arch Ophthalmol 46:11, 1951.
146.Moses RL:Theory and calibration of the Schiøtz tonometer, Invest Ophthalmol 10:534, 1971.
147.Ericson LA:Twenty-four hourly variations on the aqueous flow: examination with perilimbal suction cup,Acta Ophthalmol Scand Suppl 50:1, 1958.
148.Langham ME, Maumenee AE:The diagnosis and treatment of glaucoma based on a new procedure for the measurement of ocular dynamics,Trans Am Acad Ophthalmol Otolaryngol 68:227, 1964.
149.Rosengren B:A method for producing intraocular rise in tension,Acta Ophthalmol Scand Suppl 12:403, 1934.
150.Rosengren B: Rise in the ocular tension produced by circumlimbal pressure on the sclera,Trans Ophthalmol Soc UK 76:65, 1956.
151.Langham ME, Eisenlohr JE:A manometric study of the rate of fall of the intraocular pressure in the living and dead eyes of human subjects, Invest Ophthalmol 2:72, 1963.
152.Holm O:A photogrammetric method for estimation of the pupillary aqueous flow in the living human eye, I,Acta Ophthalmol 46:254, 1968.
153.Holm O,Wiebert O:A photogrammetric method for estimation of the pupillary aqueous flow in the living human eye. II. Statistical evaluation of pupillary flow measurements,Acta Ophthalmol 46:1230, 1968.
154.Macri RJ, O’Rourke J: Measurements of aqueous humor turnover rates using a gamma probe,Arch Ophthalmol 83:741, 1970.
155.O’Rourke J: Nuclear ophthalmology: dynamic function studies in intraocular disease, Philadelphia, WB Saunders, 1976.
156.Davson H, Spaziani E:The fate of substances injected into the anterior chamber of the eye, J Physiol 151:202, 1960.
157.Sperber GO, Bill A:A method of near-continuous determination of aqueous humor flow; effects of anesthetics, temperature and indomethacin, Exp Eye Res 39:435, 1984.
158.Maurice DM: Protein dynamics in the eye studied with labelled proteins,Am J Ophthalmol 47:361, 1959.
159.Bill A, Hellsing K: Production and drainage of aqueous humour in the cynomolgus monkey Macaca irus with evidence for unconventional routes, Invest Ophthalmol 4:920, 1965.
160.Barany EH, KinseyVE:The rate of flow of aqueous humor: I.The rate of disappearance of paraaminohippuric acid, radioactive Rayopake and radioactive Diodrast from the aqueous humor of rabbits,Am J Ophthalmol 32:177, 1949.
161.KinseyVE, Barany EH:The rate of flow of aqueous humor: II. Derivation of rate of flow and its
physiologic significance,Am J Ophthalmol 32:189, 1949.
162.Amsler H, Huber A: Methodik and urste klinische Ergebnisse einer Functionsprufund der Blut- Kammerwasser-Schranke, Ophthalmologica 111:155, 1946.
163.Araie M,Takase M: Effects of various drugs on aqueous humor dynamics in man, Jpn J Ophthalmol 25:91, 1981.
164.Araie M, et al:Aqueous humor dynamics in man as studied by oral fluorescein, Jpn J Ophthalmol 24:346, 1980.
165.Goldmann H: Uber Fluorescein in der menschlichenVorderkammer: Das KammerwasserMinutenvolumen des Menschen, Ophthalmologica 119:65, 1950.
166.Goldmann H:Abflussdruck, Minutenvolumen und Widerstand der Kammerwasserstromung des Menschen, Doc Ophthalmol 5–6:278, 1951.
167.Nagataki S:Aqueous humor dynamics of human eyes as studied using fluorescein, Jpn J Opthalmol 19:235, 1975.
168.Nagataki S, Mishima S:Aqueous humor dynamics in glaucomato-cyclitic crisis, Invest Ophthalmol 15:365, 1976.
169.Dyster-Aas K, Krakau CET:Aqueous flow determination in the rabbit by means of a minimal eye trauma, Invest Ophthalmol 3:127, 1964.
170.Brubaker RF, Gaasterland D:The effect of isoproterenol on aqueous humor formation in humans, Invest OphthalmolVis Sci 25:357, 1984.
171.Carlson KH, McLaren JW, Brubaker. RF:The effect of body position on intraocular pressure and aqueous flow, Invest OphthalmolVis Sci 28:1346, 1987.
172.Coakes RL, Brubaker RF:The mechanism of timolol in lowering intraocular pressure,Arch Ophthalmol 96:2045, 1978.
173.Dailey RA, Brubaker RF, Bourne.WM:The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects,Am J Ophthalmol 93:232, 1982.
174.Jones RF, Maurice DM: New methods for measuring the rate of aqueous flow in man with fluorescein, Exp Eye Res 5:208, 1966.
175.Langley D, MacDonald RK: Clinical method of observing changes in the rate of flow of aqueous humor in the human eye. I. Normal eyes, Br J Ophthalmol 36:432, 1952.
176.Lee DA, Brubaker RF, Nagataki S: Effect of thymoxamine on aqueous humor formation in the normal human eye as measured by fluorophotometry, Invest OphthalmolVis Sci 21:805, 1981.
177.Lee DA,Topper JE, Brubaker RF: Effects of clonidine on aqueous humor flow in normal human eyes, Exp Eye Res 38:239, 1984.
178.Nagataki S, Brubaker RF: Early effects of epinephrine on aqueous formation in the normal human eye, Ophthalmology 88:278, 1981.
179.Nagataki S, Brubaker RF: Effect of pilocarpine on aqueous humor formation in human beings,Arch Ophthalmol 100:818, 1982.
180.Reiss GR, Brubaker RF:The mechanism of betaxolol, a new ocular hypotensive agent, Ophthalmology 90:1369, 1983.
181.Reiss GR, et al:Aqueous humor flow during sleep, Invest OphthalmolVis Sci 25:776, 1984.
182.Schenker HI, et al: Fluorophotometric study of epinephrine and timolol in human subjects,Arch Ophthalmol 99:1212, 1981.
183.Starr PAJ: Changes in aqueous flow determined by fluorophotometry,Trans Ophthalmol Soc UK 86:639, 1966.
184.Townsend DJ, Brubaker RF: Intermediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry, Invest OphthalmolVis Sci 19:256, 1980.
185.Weekers R, DelmarcelleY: Hypotonie ocularie par reduction du debit de l’humeur aqueuse, Ophthalmologica 125:425, 1953.
186.Wentworth WO, Brubaker RF:Aqueous humor dynamics in a series of patients with third neuron
Horner’s syndrome,Am J Ophthalmol 92:407, 1981.
187.Johnson F, Maurice D:A simple method of measuring aqueous humor flow with intravitreal fluoresceinated dextrans, Exp Eye Res 39:791, 1984.
188.Oppelt WW: Measurement of aqueous humor formation rates by posterior-anterior chamber perfusion with inulin: normal values and the effect of carbonic anhydrase inhibition, Invest Ophthalmol 6:76, 1967.
189.Becker B:The measurement of rate of aqueous flow with iodide, Invest Ophthalmol 1:52, 1962.
190.Pollack IP, Becker B:The effect of hypothermia on aqueous humor dynamics. IV. Carotid artery
ligation and blood flow,Am J Ophthalmol 51:1039, 1961.
191.Krupin T, et al:The effect of hyperthermia on aqueous humor dynamics in rabbits,Am J Ophthalmol 83:561, 1977.
192.Krupin T, et al: Increased intraocular pressure and hypothermia following injection of calcium into the rabbit third ventricle, Exp Eye Res 27:129, 1978.
193.McLaren JW, Brubaker RF:A scanning ocular fluorophotometer, Invest OphthalmolVis Sci 29:1285, 1988.
194.Topper JE, Brubaker RF: Effects of timolol, epinephrine and acetazolamide on aqueous flow during sleep, Invest OphthalmolVis Sci 26:1315, 1985.
195.Becker B:The decline in aqueous secretion and outflow facility with age,Am J Ophthalmol 46:731, 1958.
196.Gaasterland D, et al: Studies of aqueous humor dynamics in man.VI. Effect of age on parameters of intraocular pressure in normal human eyes, Exp Eye Res 26:651, 1978.
197.Kupfer C: Clinical significance of pseudofacility,Am J Ophthalmol 75:193, 1973.
198.Lütjen-Drecoll E: Functional morphology of the ciliary epithelium. In: Lütjen-Drecoll E, editor: Basic aspects of glaucoma research, Stuttgart, Schattauer, 1982.
199.Bill.A:The effect of ocular hypertension caused by red cells on the rate of formation of aqueous humor, Invest Ophthalmol 7:162, 1968.
200.Anselmi P, Bron AJ, Maurice DM:Action of drugs on the aqueous flow in man measured by fluorophotometry, Exp Eye Res 7:487, 1968.
201.Araie M, et al: Effects of laser trabeculoplasty on the human aqueous humor dynamics: a
fluorophotometric study,Am J Ophthalmol 16:540, 1984.
202.Brubaker RF, Liesegang TJ: Effect of trabecular photocoagulation on the aqueous dynamics of the human eye,Am J Ophthalmol 96:139, 1983.
203.Yablonski ME, Cook DJ, Gray J:A fluorophotometric study of the effect of argon laser trabeculoplasty on aqueous humor dynamics,Am J Ophthalmol 99:579, 1985.
204.Brown JD, Brubaker RF:A study of the relation between intraocular pressure and aqueous humor flow in the pigment dispersion syndrome, Ophthalmology 96:1468, 1989.
205.Walker SD, Brubaker RF, Nagataki S: Hypotony and aqueous humor dynamics in myotonic dystrophy, Invest OphthalmolVis Sci 22:744, 1982.
206.Bill A: Effects of acetazolamide and carotid occlusion on the ocular blood flow in unanesthetized rabbits, Invest Ophthalmol 13:954, 1974.
207.Kornbluth W, Linner E: Experimental tonography in rabbits: effect of unilateral ligation of a common carotid artery on aqueous humor dynamics as studied by means of tonography and fluorescein appearance time,Arch Ophthalmol 54:717, 1955.
208.Linner E:Ascorbic acid as a test substance for measuring relative changes in the rate of plasma flow through the ciliary processes. IV.The effect of carotid ligation and cervical sympathectomy in guinea pigs on the ascorbic acid content of the aqueous humor at varying plasma levels,Acta Physiol Scand 26:130, 1952.
23
part
2 Aqueous humor dynamics
209.Ross KS, Macri RJ, Kupfer C:The effect of carotid artery ligation on aqueous humor formation in the rhesus monkey Macaca mulatta, Exp Eye Res 27:687, 1978.
210.Gloster J, Greaves DP: Effect of diencephalic stimulation upon intra-ocular pressure, Br J Ophthalmol 41:513, 1957.
211.Schmerl E, Steinberg B: Separation of diencephalic centers concerned with pupillary motility and ocular tension,Am J Ophthalmol 33:1379, 1950.
212.Von Sallmann L, Lowenstein O: Responses of intraocular pressure, blood pressure, and cutaneous vessels to electrical stimulation in the diencephalon, Am J Ophthalmol 39:11, 1955.
213.Podos SM, Krupin T, Becker B: Mechanism of intraocular pressure response after optic nerve transection,Am J Ophthalmol 72:79, 1971.
214.Riise D, Simonsen E: Intraocular pressure in unilateral optic nerve lesions,Acta Ophthalmolol Scand Suppl 47:750, 1969.
215.Smith SD, Gregory DS:A circadian rhythm of aqueous flow underlies the circadian rhythm of IOP in NZW rabbits, Invest OphthalmolVis Sci 30:775, 1989.
216.Liu JH, Neufeld AH: Study of central regulation of intraocular pressure using ventriculocisternal perfusion, Invest OphthalmolVis Sci 26:136, 1985.
217.Belmonte C, et al: Effects of stimulation of the ocular sympathetic nerves on the IOP and aqueous humor flow, Invest OphthalmolVis Sci 28:1649, 1987.
218.Bron AJ: Sympathetic control of aqueous secretion in man, Br J Ophthalmol 53:37, 1969.
219.Kass MA, Sears ML: Hormonal regulation of intraocular pressure, Surv Ophthalmol 22:153, 1977.
220.Viggiano SR,Abbound CF, Brubacker RF: Effect of desmopressin on aqueous humor flow in humans, Am J Ophthalmol 115:511, 1993.
221.Viggiano SR, et al:The effect of melatonin on aqueous humor flow in humans during the day, Ophthalmology 101:326, 1994.
222.Ziai N, et al: Beta-human chorionic gonadotropin, progesterone, and aqueous dynamics during pregnancy,Arch Ophthalmol 112:801, 1994.
223.Levene RZ, Schwartz B: Depression of plasma cortisol and the steroid ocular pressure response, Arch Ophthalmol 80:461, 1968.
224.Kacere RD, Dolan JW, Brubaker RF: Intravenous epinephrine stimulates aqueous formation in the
human eye, Invest OphthalmolVis Sci 33:2861, 1992.
225.Gharagozloo NZ, et al:Terbutaline stimulates aqueous flow in humans during sleep,Arch Ophthalmol 106:1218, 1988.
226.Caprioli J, Sears ML:The adenyl cyclase receptor complex and aqueous humor formation,Yale J Biol Med 57:283, 1984.
227.Sears ML: Regulation of aqueous flow by the adenylate cyclase receptor complex in the ciliary epithelium,Am J Ophthalmol 110:194, 1985.
228.Waitzman M,Woods W: Some characteristics of an adenyl cyclase preparation, Exp Eye Res 12:99, 1971.
229.Nathanson JA:Atriopeptin-activated guanylate cyclase in the anterior segment: identification, localization, and effects of atriopeptins on IOP, Invest OphthalmolVis Sci 28:1357, 1987.
230.Cherksey BD,Alvarado JA, Polansky JR: Ion channel activity of ciliary process epithelium vesicles reconstituted into planar bilayers, Invest OphthalmolVis Sci 29(suppl):175, 1988.
231.Polansky JR, Cherksey BR,Alvarado A: Update on beta adrenergic drug therapy. In: Drance SM, van Buskirk AM, Neufeld AH, editors:Applied pharmacology of the glaucomas, Philadelphia, Williams & Wilkins, 1991.
232.McCannel CA, et al:A study of aqueous humor formation in patients with cystic fibrosis, Invest OphthalmolVis Sci 33:160, 1992.
233.Johnson. D, Liesegang TJ, Brubaker RF:Aqueous humor dynamics in Fuchs’ uveitis syndrome,Am J Ophthalmol 95:783, 1983.
234.Pederson JE: Ocular hypotony,Trans Ophthalmol Soc UK 105:220, 1986.
235.Hayashi M, et al: Decreased formation of aqueous humor in insulin-dependent diabetic patients, Br J Ophthalmol 73:621, 1989.
236.Kimura R, Honda M: Effect of orally administered hydrocortisone on the rate of aqueous flow in man, Acta Ophthalmol Scand Suppl 60:582, 1982.
237.Samuelsson-Almén M, et al: Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey, Exp Eye Res 53:253, 1991.
238.Kalina PH, et al: 6-amino-2- benzothiazolesulfonamide: the effect of a topical carbonic anhydrase inhibitor on aqueous humor formation in the normal human eye, Ophthalmology 95:772, 1988.
239.Yablonski ME, et al:A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics, Exp Eye Res 27:135, 1978.
240.McCannel CA, Heinrich SR, Brubaker RF: Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans, Graefes Arch Clin Exp Ophthalmol 230:518, 1992.
241.Schlecht LP, Brubaker RF:The effects of withdrawal of timolol in chronically treated glaucoma patients, Ophthalmology 95:1212, 1988.
242.Gharagozloo NZ, Relf SJ, Brubaker RF:Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145), Ophthalmology 95:1217, 1988.
243.Toris CB, et al: Effects of brimonidine on aqueous humor dynamics in human eyes,Arch Ophthalmol 113:1514, 1995.
244.Becker B, Ley AP: Epinephrine and acetazolamide in the therapy of the glaucomas,Am J Ophthalmol 45:639, 1958.
245.Garner LL, et al: Effect of 2% levo-rotary epinephrine on the intraocular pressure of the glaucomatous eye,Arch Ophthalmol 62:230, 1959.
246.Weekers R, DelmarcelleY, Gustin J:Treatment of ocular hypertension by adrenaline and diverse sympathomimetic amines,Am J Ophthalmol 40:660, 1955.
247.Higgins RG, Brubaker RF:Acute effect of epinephrine on aqueous humor formation in the timolol-treated eye as measured by fluorophotometry, Invest OphthalmolVis Sci 19:420, 1980.
248.Becker B:Vanadate and aqueous humor dynamics: Proctor Lecture, Invest OphthalmolVis Sci 19:1150, 1980.
249.Krupin T, Becker B, Podos SM:Topical vanadate lowers intraocular pressure in rabbits, Invest OphthalmolVis Sci 19:1360, 1980.
250.Mittag TW, et al:Vanadate effects on ocular pressure, (Na , K )ATPase and adenylate cyclase in rabbit eyes, Invest OphthalmolVis Sci 25:1335, 1984.
251.Krupin T, et al: Halothane anesthesia and aqueous humor dynamics in laboratory animals, Invest OphthalmolVis Sci 19:518, 1980.
252.Schutten WH, van Horn DL:The effects of ketamine sedation and ketamine-pentobarbital anesthesia upon the intraocular pressure of the rabbit, Invest OphthalmolVis Sci 16:531, 1977.
24
